Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney | 15 | 2021 | 945 | 1.090 |
Why?
|
| Podocytes | 4 | 2021 | 113 | 0.780 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 2 | 2020 | 25 | 0.770 |
Why?
|
| Kidney Diseases | 5 | 2020 | 307 | 0.650 |
Why?
|
| Angiotensinogen | 1 | 2017 | 18 | 0.600 |
Why?
|
| Kidney Glomerulus | 5 | 2021 | 155 | 0.600 |
Why?
|
| TRPP Cation Channels | 1 | 2017 | 20 | 0.600 |
Why?
|
| Fumarates | 1 | 2017 | 28 | 0.600 |
Why?
|
| Renin | 1 | 2017 | 96 | 0.590 |
Why?
|
| Renin-Angiotensin System | 1 | 2017 | 79 | 0.580 |
Why?
|
| Angiotensin I | 2 | 2014 | 24 | 0.570 |
Why?
|
| Amides | 1 | 2017 | 86 | 0.570 |
Why?
|
| Angiotensin II | 4 | 2015 | 220 | 0.540 |
Why?
|
| Peptide Fragments | 3 | 2014 | 483 | 0.500 |
Why?
|
| Sodium | 2 | 2008 | 161 | 0.480 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2014 | 43 | 0.470 |
Why?
|
| Renal Circulation | 4 | 2008 | 49 | 0.470 |
Why?
|
| Kinins | 3 | 2008 | 109 | 0.460 |
Why?
|
| Hypertension | 4 | 2020 | 1535 | 0.430 |
Why?
|
| Citrate (si)-Synthase | 3 | 2003 | 11 | 0.410 |
Why?
|
| Aldosterone | 4 | 2003 | 51 | 0.410 |
Why?
|
| Nephrectomy | 4 | 2017 | 103 | 0.350 |
Why?
|
| Receptor, Bradykinin B2 | 3 | 2008 | 75 | 0.350 |
Why?
|
| Rats | 18 | 2020 | 5300 | 0.340 |
Why?
|
| Kidney Medulla | 3 | 2008 | 17 | 0.340 |
Why?
|
| Animals | 30 | 2022 | 20881 | 0.330 |
Why?
|
| Polycystic Kidney Diseases | 2 | 2020 | 39 | 0.300 |
Why?
|
| Glomerulonephritis | 2 | 2019 | 77 | 0.290 |
Why?
|
| Blood Pressure | 7 | 2020 | 1451 | 0.290 |
Why?
|
| Bradykinin | 4 | 2008 | 157 | 0.260 |
Why?
|
| Signal Transduction | 6 | 2021 | 2689 | 0.230 |
Why?
|
| Mice, Knockout | 5 | 2022 | 1692 | 0.230 |
Why?
|
| Tetrazoles | 2 | 2020 | 160 | 0.200 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2020 | 155 | 0.200 |
Why?
|
| Vitamin A | 1 | 2022 | 111 | 0.190 |
Why?
|
| Retinoids | 1 | 2022 | 122 | 0.190 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2021 | 63 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2015 | 2083 | 0.180 |
Why?
|
| Valsartan | 1 | 2020 | 99 | 0.180 |
Why?
|
| Aminobutyrates | 1 | 2020 | 94 | 0.170 |
Why?
|
| Male | 19 | 2020 | 37321 | 0.170 |
Why?
|
| Formoterol Fumarate | 1 | 2019 | 25 | 0.170 |
Why?
|
| Glutamyl Aminopeptidase | 2 | 2017 | 12 | 0.170 |
Why?
|
| Hypertension, Renovascular | 2 | 1996 | 47 | 0.160 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2019 | 18 | 0.160 |
Why?
|
| Enalapril | 2 | 1996 | 86 | 0.160 |
Why?
|
| Myosin Type I | 1 | 2019 | 20 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2017 | 118 | 0.160 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2019 | 27 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 2550 | 0.160 |
Why?
|
| Nephrotic Syndrome | 1 | 1999 | 61 | 0.160 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2008 | 317 | 0.160 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2017 | 48 | 0.150 |
Why?
|
| Cell Proliferation | 3 | 2017 | 1174 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2021 | 617 | 0.140 |
Why?
|
| HEK293 Cells | 2 | 2015 | 326 | 0.140 |
Why?
|
| Radioligand Assay | 2 | 2014 | 109 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 384 | 0.140 |
Why?
|
| Dietary Proteins | 1 | 1996 | 51 | 0.140 |
Why?
|
| Enalaprilat | 1 | 1996 | 4 | 0.140 |
Why?
|
| Albumins | 1 | 1996 | 72 | 0.130 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1996 | 81 | 0.130 |
Why?
|
| ErbB Receptors | 1 | 2017 | 239 | 0.130 |
Why?
|
| Rats, Wistar | 5 | 2000 | 371 | 0.130 |
Why?
|
| Calcium Channels | 1 | 2015 | 59 | 0.120 |
Why?
|
| Mice | 7 | 2022 | 8474 | 0.120 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1996 | 202 | 0.120 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2020 | 50 | 0.120 |
Why?
|
| Phenotype | 1 | 2017 | 947 | 0.120 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 215 | 0.120 |
Why?
|
| Mitochondria | 1 | 2019 | 643 | 0.120 |
Why?
|
| Apoptosis | 2 | 2019 | 1641 | 0.120 |
Why?
|
| Treatment Failure | 1 | 2014 | 216 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 786 | 0.120 |
Why?
|
| Disease Progression | 1 | 2017 | 1038 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2015 | 201 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2015 | 158 | 0.110 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 567 | 0.110 |
Why?
|
| Time Factors | 4 | 2017 | 4655 | 0.110 |
Why?
|
| Calcium | 2 | 2015 | 929 | 0.110 |
Why?
|
| Bradykinin Receptor Antagonists | 3 | 1998 | 20 | 0.110 |
Why?
|
| Rats, Inbred WF | 3 | 2003 | 14 | 0.110 |
Why?
|
| Receptor, Angiotensin, Type 1 | 3 | 2008 | 80 | 0.100 |
Why?
|
| Adrenalectomy | 2 | 2003 | 17 | 0.100 |
Why?
|
| Receptors, Angiotensin | 2 | 2005 | 59 | 0.100 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2011 | 31 | 0.090 |
Why?
|
| Cilia | 1 | 2011 | 94 | 0.090 |
Why?
|
| Kidney Function Tests | 3 | 2015 | 114 | 0.090 |
Why?
|
| Urine | 2 | 2008 | 47 | 0.090 |
Why?
|
| Sodium Chloride | 3 | 2006 | 136 | 0.080 |
Why?
|
| Fibrosis | 2 | 2019 | 371 | 0.080 |
Why?
|
| Receptors, Vasopressin | 1 | 2008 | 5 | 0.080 |
Why?
|
| Dithiothreitol | 1 | 2008 | 17 | 0.080 |
Why?
|
| Antioxidants | 2 | 2008 | 304 | 0.080 |
Why?
|
| Desoxycorticosterone | 2 | 2000 | 41 | 0.080 |
Why?
|
| Bradykinin B2 Receptor Antagonists | 1 | 2008 | 13 | 0.080 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2008 | 23 | 0.080 |
Why?
|
| Biopsy | 1 | 2010 | 540 | 0.080 |
Why?
|
| Albuminuria | 3 | 1999 | 171 | 0.080 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2008 | 45 | 0.080 |
Why?
|
| Doxorubicin | 2 | 2019 | 231 | 0.080 |
Why?
|
| Biphenyl Compounds | 2 | 2020 | 184 | 0.070 |
Why?
|
| Osmolar Concentration | 3 | 2008 | 134 | 0.070 |
Why?
|
| Reference Values | 2 | 1999 | 579 | 0.070 |
Why?
|
| Cell Line | 2 | 2021 | 1752 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 2 | 2021 | 274 | 0.070 |
Why?
|
| Phytosterols | 1 | 2005 | 8 | 0.070 |
Why?
|
| Membrane Transport Proteins | 1 | 2006 | 81 | 0.060 |
Why?
|
| Peptides | 2 | 2021 | 455 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2005 | 112 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2005 | 120 | 0.060 |
Why?
|
| Lipoproteins | 1 | 2005 | 161 | 0.060 |
Why?
|
| Female | 6 | 2019 | 38074 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2005 | 144 | 0.060 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2003 | 3 | 0.050 |
Why?
|
| Protein Binding | 2 | 2021 | 1027 | 0.050 |
Why?
|
| Retinol-Binding Proteins | 1 | 2022 | 28 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 47 | 0.050 |
Why?
|
| Acetylcysteine | 1 | 2005 | 296 | 0.050 |
Why?
|
| Intercellular Junctions | 1 | 2021 | 32 | 0.050 |
Why?
|
| Humans | 7 | 2021 | 68618 | 0.050 |
Why?
|
| Zebrafish | 1 | 2022 | 187 | 0.050 |
Why?
|
| Organ Size | 2 | 1999 | 242 | 0.050 |
Why?
|
| Up-Regulation | 3 | 2011 | 682 | 0.050 |
Why?
|
| Rats, Inbred Dahl | 1 | 2020 | 48 | 0.050 |
Why?
|
| Retina | 1 | 2022 | 252 | 0.040 |
Why?
|
| Interferon Regulatory Factors | 1 | 2020 | 24 | 0.040 |
Why?
|
| Gene Expression | 1 | 2003 | 770 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 562 | 0.040 |
Why?
|
| Absorption | 2 | 1996 | 49 | 0.040 |
Why?
|
| Biological Transport | 1 | 2000 | 210 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2020 | 304 | 0.040 |
Why?
|
| Cell Membrane | 2 | 2015 | 525 | 0.040 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2019 | 51 | 0.040 |
Why?
|
| Organelle Biogenesis | 1 | 2019 | 34 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2019 | 34 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 1999 | 1040 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2022 | 597 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 196 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2021 | 1200 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 1999 | 306 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 1999 | 152 | 0.040 |
Why?
|
| Hemodynamics | 3 | 2015 | 705 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2015 | 1330 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1293 | 0.040 |
Why?
|
| Disulfides | 2 | 2008 | 40 | 0.040 |
Why?
|
| Sodium, Dietary | 1 | 1997 | 31 | 0.040 |
Why?
|
| Random Allocation | 2 | 2015 | 442 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 615 | 0.040 |
Why?
|
| Chlorides | 1 | 1996 | 68 | 0.030 |
Why?
|
| Macrophages | 1 | 2020 | 647 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1997 | 150 | 0.030 |
Why?
|
| Kidney Tubules, Collecting | 1 | 1996 | 46 | 0.030 |
Why?
|
| Microinjections | 1 | 1996 | 130 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 179 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 1996 | 168 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 1996 | 179 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2015 | 57 | 0.030 |
Why?
|
| Water | 1 | 1996 | 230 | 0.030 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2015 | 63 | 0.030 |
Why?
|
| Imidazoles | 1 | 1995 | 175 | 0.030 |
Why?
|
| Diuresis | 2 | 2008 | 20 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2015 | 235 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 135 | 0.030 |
Why?
|
| Lysophospholipids | 1 | 2015 | 209 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 791 | 0.030 |
Why?
|
| Sphingosine | 1 | 2015 | 315 | 0.030 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1993 | 54 | 0.030 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1993 | 40 | 0.030 |
Why?
|
| Cyclic GMP | 1 | 1993 | 99 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2008 | 2673 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2011 | 89 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 194 | 0.020 |
Why?
|
| Creatinine | 1 | 2010 | 243 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 546 | 0.020 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2008 | 15 | 0.020 |
Why?
|
| Neprilysin | 1 | 2009 | 55 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 1083 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 2791 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 1447 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2010 | 328 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 175 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 306 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 1465 | 0.020 |
Why?
|
| Atlantic Ocean | 1 | 2006 | 22 | 0.020 |
Why?
|
| Acclimatization | 1 | 2006 | 14 | 0.020 |
Why?
|
| Seawater | 1 | 2006 | 29 | 0.020 |
Why?
|
| Fresh Water | 1 | 2006 | 43 | 0.020 |
Why?
|
| Sitosterols | 1 | 2005 | 8 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2005 | 18 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2005 | 7 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 357 | 0.020 |
Why?
|
| Thioctic Acid | 1 | 2005 | 6 | 0.020 |
Why?
|
| Inositol Phosphates | 1 | 2005 | 28 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2005 | 95 | 0.020 |
Why?
|
| Vitamin E | 1 | 2005 | 55 | 0.020 |
Why?
|
| Phosphates | 1 | 2005 | 72 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2005 | 254 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1851 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 200 | 0.020 |
Why?
|
| Biomarkers | 1 | 2010 | 1593 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2010 | 2007 | 0.010 |
Why?
|
| Body Weight | 2 | 1997 | 554 | 0.010 |
Why?
|
| Temperature | 1 | 2005 | 341 | 0.010 |
Why?
|
| South Carolina | 1 | 2010 | 2752 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 1047 | 0.010 |
Why?
|
| Oxygen | 1 | 2005 | 386 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 499 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1745 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2010 | 7277 | 0.010 |
Why?
|
| Potassium | 1 | 1997 | 168 | 0.010 |
Why?
|
| Species Specificity | 1 | 1997 | 303 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1996 | 532 | 0.010 |
Why?
|
| Heart Rate | 1 | 1998 | 568 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1996 | 223 | 0.010 |
Why?
|
| Aorta | 1 | 1997 | 316 | 0.010 |
Why?
|
| Losartan | 1 | 1995 | 45 | 0.010 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 1993 | 11 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 1993 | 25 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1993 | 165 | 0.010 |
Why?
|
| Glomerular Mesangium | 1 | 1993 | 53 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1997 | 1664 | 0.010 |
Why?
|
| Middle Aged | 1 | 2010 | 21147 | 0.010 |
Why?
|
| Adult | 1 | 2010 | 21403 | 0.010 |
Why?
|